Discovery, characterization, and pharmaceutical applications of two loratadine- oxalic acid cocrystals

Loading...
Thumbnail Image

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

Discovery, characterization, and pharmaceutical applications of two loratadine- oxalic acid cocrystals

Published Date

2020-08

Publisher

Type

Thesis or Dissertation

Abstract

Crystallization of multi-component crystals is widely used in pharmaceutical science to enhance the physiochemical properties, such as stability, mechanical properties and solubility. Loratadine (Lor) is a BCS II antihistamine drug commonly used to relieve the symptoms of allergy. It has high permeability but low solubility at physiological pHs. To overcome the problem of low solubility, we synthesized and fully characterized two Loratadine multi-component crystalline phases with oxalic acid (Oxa), i.e., a 1:1 Lor-Oxa conjugate acid-base cocrystal (Lor-Oxa CAB) and a 2:1 Lor-Oxa cocrystal monohydrate (Lor-Oxa hydrate). Both cocrystals exhibited adequate physical stability, enhanced solubility and, higher intrinsic dissolution rate than Lor. The intrinsic dissolution rate of Lor-Oxa CAB is 90 times that of Lor, which makes it a promising candidate for tablet formulation development.

Description

University of Minnesota M.S. thesis. 2020. Major: Pharmaceutics. Advisor: Changquan Sun. 1 computer file (PDF); 64 pages.

Related to

Replaces

License

Series/Report Number

Funding information

Isbn identifier

Doi identifier

Previously Published Citation

Suggested citation

Liang, Zhengxuan. (2020). Discovery, characterization, and pharmaceutical applications of two loratadine- oxalic acid cocrystals. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/224887.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.